{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:38:16Z","timestamp":1767865096041,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1998,6]]},"DOI":"10.1007\/bf03350769","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T23:01:22Z","timestamp":1397170882000},"page":"348-352","source":"Crossref","is-referenced-by-count":40,"title":["Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism"],"prefix":"10.1007","volume":"21","author":[{"given":"Y.","family":"\u015eahin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Kele\u015ftimur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"M\u00fcderris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,11]]},"reference":[{"key":"BF03350769_CR1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003081-199009000-00028","volume":"33","author":"RL Barbieri","year":"1990","unstructured":"Barbieri R.L. Hyperandrogenic disorders. Clin. Obstet. Gynecol. 33: 640, 1990.","journal-title":"Clin. Obstet. Gynecol."},{"key":"BF03350769_CR2","first-page":"2559","volume":"80","author":"RS Rittmaster","year":"1995","unstructured":"Rittmaster R.S. Medical treatment of androgen-dependent hirsutism. J. Clin. Endocrinol. Metab. 80: 2559, 1995.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350769_CR3","first-page":"903","volume":"59","author":"F Neumann","year":"1977","unstructured":"Neumann F. Pharmacology and potential use of cyproterone acetate. Horm. Metab. 59: 903, 1977.","journal-title":"Horm. Metab."},{"key":"BF03350769_CR4","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/00003081-199112000-00023","volume":"34","author":"EA Schriock","year":"1991","unstructured":"Schriock E.A., Schriock E.D. Treatment of hirsutism. Clin. Obstet Gynecol. 34: 852, 1991.","journal-title":"Clin. Obstet Gynecol."},{"key":"BF03350769_CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/j.1875-9114.1993.tb02739.x","volume":"13","author":"SL Sudduth","year":"1993","unstructured":"Sudduth S.L., Koronkowski M.J. Finasteride: the first 5 alpha-reductase inhibitor. Pharmacotherapy 13: 309, 1993.","journal-title":"Pharmacotherapy"},{"key":"BF03350769_CR6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJM199401133300208","volume":"330","author":"R S Rittmaster","year":"1994","unstructured":"Rittmaster R S. Finasteride. N. Eng. J. Med. 330: 120, 1994.","journal-title":"N. Eng. J. Med."},{"key":"BF03350769_CR7","first-page":"831","volume":"79","author":"F Fruzetti","year":"1994","unstructured":"Fruzetti F., Lorenzo D., Parrini D., Ricci C. Effects of finasteride, a 5\u03b1-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women. J. Clin. Endocrinol. Metab. 79: 831, 1994.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350769_CR8","first-page":"1115","volume":"79","author":"P Moghetti","year":"1994","unstructured":"Moghetti P., Castello R., Magnani C.M., Tosi F., Negri C., Armanini D., Bellotti G., Muggeo M. Clinical and hormonal effects of the 5\u03b1-reductase inhibitor finasteride in idiopathic hirsutism. J. Clin. Endocrinol. Metab. 79: 1115, 1994.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350769_CR9","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","volume":"140","author":"R Hatch","year":"1981","unstructured":"Hatch R., Rosenfield R., Kim M.H., Tredway D. Hirsutism: implications, etiology, and management. Am. J. Obstet. Gynecol. 140: 815, 1981.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BF03350769_CR10","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0022-4731(75)90311-8","volume":"6","author":"J Hammerstein","year":"1975","unstructured":"Hammerstein J., Meckies J., Leo-Rossberg J. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism. J. Steroid Biochem. 6: 827, 1975.","journal-title":"J. Steroid Biochem."},{"key":"BF03350769_CR11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0300-595X(86)80030-5","volume":"15","author":"RR Tremblay","year":"1986","unstructured":"Tremblay R.R. Treatment of hirsutism with spironolactone. J. Clin. Endocrinol. Metab. 15: 363, 1986.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350769_CR12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0015-0282(16)58442-8","volume":"66","author":"I M\u00fcderris","year":"1996","unstructured":"M\u00fcderris I., Bayram F., \u015eahin Y., Kele\u015ftimur F., Tutu\u015f A., Ayata D. The efficacy of 250 mg\/day flutamide in the treatment of patients with hirsutism. Fertil. Steril. 66: 220, 1996.","journal-title":"Fertil. Steril."},{"key":"BF03350769_CR13","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0015-0282(16)49873-0","volume":"46","author":"S Belisle","year":"1986","unstructured":"Belisle S., Love E.J. Clinical efficacy and safety of cyproterone acetate in severe hirsutism: result of a multycentred Canadian study. Fertil. Steril. 46: 1015, 1986.","journal-title":"Fertil. Steril."},{"key":"BF03350769_CR14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2265.1991.tb03489.x","volume":"35","author":"JH Barth","year":"1991","unstructured":"Barth J.H., Cherry C.A., Wojnarowska F., Dawber R.P.R. Cyproterone acetate for severe hirsutism: results of a double-blind dose ranging study. Clin. Endocrinol. (Oxf.) 35: 5, 1991.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03350769_CR15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1210\/jcem-60-2-349","volume":"60","author":"P Serafini","year":"1985","unstructured":"Serafini P., Ablan F., Lobo R.A. 5\u03b1-reductase activity in the genital skin of hirsute women. J. Clin. Endocrinol. Metab. 60: 349, 1985.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350769_CR16","first-page":"233","volume":"80","author":"IA Wong","year":"1995","unstructured":"Wong I.A., Morris R.S., Chang L., Spahn M.-A., Stanczyk F.Z., Lobo R.A. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women. J. Clin. Endocrinol. Metab. 80: 233, 1995.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350769_CR17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0015-0282(16)57727-9","volume":"64","author":"L Ciotta","year":"1995","unstructured":"Ciotta L., Cianci A., Calogero A.E., Palumbo M.A., Marietta E., Sciuto A., Palumbo G. Clinical and endocrine effects of finasteride, 5\u03b1-re-ductase inhibitor, in women with idiopathic hirsutism. Fertil. Steril. 64: 299, 1995.","journal-title":"Fertil. Steril."},{"key":"BF03350769_CR18","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0015-0282(16)58627-0","volume":"66","author":"R Castello","year":"1996","unstructured":"Castello R., Tosi F., Perrone F., Negri C., Muggeo M., Moghetti P. Outcome of long-term treatment with the 5\u03b1-reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects during a 1-year cours of therapy and 1-year follow-up. Fertil. Steril. 66: 734, 1996.","journal-title":"Fertil. Steril."},{"key":"BF03350769_CR19","first-page":"903","volume":"59","author":"F Neumann","year":"1977","unstructured":"Neumann F. Pharmacology and potential use of cyproterone acetate Horm. Metab. 59: 903, 1977.","journal-title":"Metab."},{"key":"BF03350769_CR20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jcem-47-3-581","volume":"47","author":"J Girard","year":"1978","unstructured":"Girard J., Baumann K.B., Buchler U., Zuppinger K., Haas H.G., Staup J.J., Wyss H.I. Cyproterone acetate and ACTH adrenal function. J. Clin. Endocrinol. Metab. 47: 581, 1978.","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03350769.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03350769\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03350769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T10:56:44Z","timestamp":1648810604000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03350769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["BF03350769"],"URL":"https:\/\/doi.org\/10.1007\/bf03350769","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}